Depakote News and Research

RSS
Six ways physicians can help optimize reproductive health in women with epilepsy

Six ways physicians can help optimize reproductive health in women with epilepsy

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Neurologists appear unaware of serious safety risks associated with anti-epilepsy drugs

Neurologists appear unaware of serious safety risks associated with anti-epilepsy drugs

Medicaid fraud settlement becomes part of Virginia gubernatorial campaign

Medicaid fraud settlement becomes part of Virginia gubernatorial campaign

First Edition: June 6, 2013

First Edition: June 6, 2013

FDA: Migraine prevention medicines taken during pregnancy can impact children’s IQ

FDA: Migraine prevention medicines taken during pregnancy can impact children’s IQ

Roundup: States raise employee insurance contributions to save money; Minn. seeking $80M more for exchange; Selling insurance in malls

Roundup: States raise employee insurance contributions to save money; Minn. seeking $80M more for exchange; Selling insurance in malls

Court approves Abbott settlement for wrongly marketing Depakote

Court approves Abbott settlement for wrongly marketing Depakote

First Edition: October 3, 2012

First Edition: October 3, 2012

New evidence reveals possibility of mood-enhancing effects associated with some flavors

New evidence reveals possibility of mood-enhancing effects associated with some flavors

First Edition: May 8, 2012

First Edition: May 8, 2012

Abbott to resolve all outstanding issues related to Depakote

Abbott to resolve all outstanding issues related to Depakote

Migraine prevention guidelines released

Migraine prevention guidelines released

NPR: The Abbott Lab breakup

NPR: The Abbott Lab breakup

Mylan introduces Divalproex Sodium Capsules for treatment of seizures

Mylan introduces Divalproex Sodium Capsules for treatment of seizures

GSK receives FDA approval for Lamictal XR to treat partial seizures

GSK receives FDA approval for Lamictal XR to treat partial seizures

Mylan second-quarter adjusted diluted EPS increases to $0.37

Mylan second-quarter adjusted diluted EPS increases to $0.37

Mylan first-quarter total revenues increase 7% to $1.29 billion

Mylan first-quarter total revenues increase 7% to $1.29 billion

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%